Meet VitalOne, a compact blood analysis device designed with the latest advances in robotics, biochemistry, computer vision, and microfluidics to deliver lab-grade results in the doctor’s office in minutes.
Cofounder and CEO of Vital BioVasu Nadella offered a live introduction to the #FortuneHealth audience. bit.ly/3Wsi6Ph
If I don't want only uses 600 microliters of blood. That's less than 3% of what's typically used for a comprehensive panel like this. What that means is you can use either vacutainers or micro retainers from a fingerstick sample. So when you're gonna drop the mic retainers today into the Vital 1? And then he's going to slide in our two consumable components, a disc pack and a support pack. And from there, he's gonna hit go. In less than 15 seconds of hands on time, we're gonna return within 15 to 20 minutes a comprehensive panel of tests including a complete blood count, comprehensive metabolic panel, lipid panel, HBA, 1C for diabetes and immuno acids like thyroid stimulating hormone or vitamin D covering common and guideline recommended tests. Let's contrast. This is what happens today. We draw tubes and tubes of blood from patients. Then it takes over an hour to let that blood clot centrifuge. And process it to get sent across the country to be run and have lab results returned days later. Instead with the vital one, we're going to enable patients to get their blood drawn while they're getting groomed and by the time the physician is ready to see them, they're going to have access to a comprehensive panel of tests to enable what we call real time medicine. So.
It was amazing to actually touch-see-experience what Vasu Nadella is building at Vital Bio. I met Vasu nearly two years ago when he had a concept and conviction on fixing laboratory testing. Now, Vital Bio is on the verge of disrupting and improving the current clunky ecosystem of point-of-care testing in a major way!
Médico Cirujana,Empresaria, Inversionista, Gestión de Servicios de Salud, Amante del arte y música.
Medical surgeon/Emergency and disaster brigadier/ Investor/ Healthcare management/ Lover of contemporary art and music.
Assistant Professor of Information Systems and Supply Chain Management | Ph.D. Electrical Engineering | Ph.D. Big Data Analytics
5moThis is exactly what Theranos and Elizabeth Holmes did. I don't know why people are still following and funding this idea.